Stocksigma LogoStocksigma Logo

AstraZeneca Pharma India Schedules Board Meeting on 5th Nov'26 to Consider Q2 Results

AstraZeneca Pharma India Limited announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the unaudited financial results for

AstraZeneca Pharma India Schedules Board Meeting on 5th Nov'26 to Consider Q2 Results

AstraZeneca Pharma India Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

AstraZeneca Pharma India Schedules Board Meeting on 5th Nov'26 to Consider Q2 Results AstraZeneca Pharma India Limited announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for designated persons remains closed from 16th Sep'26 to 7th Nov'26 (both days inclusive) in compliance with SEBI insider trading regulations.

Original exchange filing (PDF)

More announcements from AstraZeneca Pharma India Ltd

All AstraZeneca Pharma India Ltd announcements